The hydroxychloroquine for COVID-19 market is anticipated to grow at a significant CAGR of 3.4% during the forecast period (2022-2028). Hydroxychloroquine raises endosomal pH, which prevents SARS-CoV-2 from fusing to the host cell membrane. Chloroquine prevents the cellular angiotensin-converting enzyme 2 (ACE2) receptor from being glycosylated, which may prevent SARS-CoV from attaching to the cell receptor. In vitro investigations, it has been revealed that hydroxychloroquine may prevent the viral genome from being released by blocking the transfer of SARS-CoV-2 from early endosomes to endolysosomes. Immunomodulatory actions of hydroxychloroquine have also been proposed as a possible mechanism of action for the treatment of COVID-19. The major factor driving the growth of the global hydroxychloroquine for COVID-19 market is the rising cases of COVID-19 globally.
A full report Hydroxychloroquine for COVID-19 Market of is available at: : https://orionmarketreports.com/hydroxychloroquine-for-covid-19-market/105202/
The global hydroxychloroquine for COVID-19 market is segmented based on type and application. Based on type, the market is sub-segmented into hospitals, clinics, and COVID-19 care centres. Based on the distribution channel, the market is sub-segmented into hospital pharmacy, retail pharmacy, and online pharmacy. Among these distribution channels, the hospital segment is expected to propel the growth of the market due to the increasing usage of hydroxychloroquine drugs in the treatment of COVID-19 patients. Although the drug is not approved officially by the USFDA, it is being used heavily in the treatment of COVID-19 patients. The FDA assessed that chloroquine and hydroxychloroquine are unlikely to be effective in treating COVID-19 for the permitted purposes under the EUA based on its ongoing study of the EUA and developing scientific evidence.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Application
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape-Bayer AG, Rising Pharmaceutical Ltd., Sun Pharmaceutical Industries Ltd., Shanghai Pharma Ltd., Novartis International AG, and Sanofi SA, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Hydroxychloroquine for COVID-19 Market Report by Segment
By Application
- Hospitals
- Clinics
- COVID-19 Care Centres
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic coverage
- North America market size and/or volume
- Latin America market size and/or volume
- Europe market size and/or volume
- Asia-pacific market size and/or volume
- Rest of the world market size and/or volume
Recent Developments
- Market Overview and growth analysis
- Import and Export Overview
- Volume Analysis
- Current Market Trends and Future Outlook
- Market Opportunistic and Attractive Investment Segment
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
